Literature DB >> 20862632

Partial splenic embolization as an alternative to splenectomy in hypersplenism--single center experience in 16 years.

G Alzen1, J Basedow, M Luedemann, L D Berthold, K-P Zimmer.   

Abstract

PROBLEM: In young patients with hypersplenism splenectomy implies a lifelong increased risk for post-splenectomy infection. Especially in children, whose immune system is not yet completely matured, the risk for some bacterial infection may increase after splenectomy because the spleen helps to defend against encapsulated bacteria like pneumococci, meningococci and haemophilus influenzae. We present partial splenic embolization as an alternative to surgical splenectomy.
METHOD: Partial splenic embolization was performed in 17 patients from 1-31 years with hypersplenism of various etiologies and was achieved by selective catheterization of splenic arteries and injection of 150-355 μm polyvinyl alcohol particles (Ivalon (®)). After the intervention the patients received an intensified analgesic regimen and antibiotics to avoid concurrent infectious complications.
RESULTS: Partial splenic embolization represented between 30-60% of the splenic volume and was followed in general by an immediate increase of all blood cells and symptoms of hypersplenism were reduced. In 2 patients the procedure was repeated because the result of the first embolization was insufficient in one patient and became necessary in another in the long run. Post-procedural side effects included fever, abdominal pain, ascites and pleural effusions. There were no acute infections in any patient.
CONCLUSION: Our monoinstitutional experiences over 16 years offer, partial splenic embolization in patients with hypersplenism from miscellaneous reasons as a low-risk alternative to surgical splenectomy. The procedure can be repeated as necessary, but it is always a temporary palliation depending on the underlying disease which often leads to liver transplantation. Using intensive analgesia and antibiotics side effects were tolerable, and patients could be discharged after a few days. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 20862632     DOI: 10.1055/s-0030-1263183

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  5 in total

1.  Laparoscopic ligation of splenic vessels for the treatment of hereditary spherocytosis in children.

Authors:  Jin-Shan Zhang; Long Li
Journal:  Pediatr Surg Int       Date:  2020-01-25       Impact factor: 1.827

2.  Laparoscopic splenic vessels ligation as a treatment of hypersplenism and thrombocytopenia in children.

Authors:  Jin-Shan Zhang; Long Li; Qi Li; Wei Cheng
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

3.  Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis.

Authors:  Wei Li; Shi-Qiang Shen; Shan-Min Wu; Zu-Bing Chen; Chao Hu; Rui-Chen Yan
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

4.  Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.

Authors:  Yingying Li; Zuojin Liu; Chang'an Liu
Journal:  BMC Gastroenterol       Date:  2021-02-11       Impact factor: 3.067

5.  Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy.

Authors:  Zong-Tao Chai; Xiu-Ping Zhang; Min Shao; Jian-Yang Ao; Zhen-Hua Chen; Fan Zhang; Yi-Ren Hu; Cheng-Qian Zhong; Jian-Hua Lin; Kun-Peng Fang; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal:  Ann Transl Med       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.